Oxford Researchers Received Funding to create world’s first ovarian cancer prevention vaccine
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
-
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Radiology | Therapeutics | Women's Health
FDA Cleared 23andMe improved BRCA report for communities underrepresented in genetic testing
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
-
FDA authorized direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
On Mar. 6, 2018, the U.S. Food and Drug Administration (FDA) authorized 23andMe’s Personal Genome Service Genetic Health…
-
OMRF researchers found that BRCA1 and BRCA2 genes may predict breast cancer risk in women
On May 24, 2001, Dr. Eldon Jupe and a team of Oklahoma Medical Research Foundation (OMRF) researchers found…
-
BRCA2 gene mapped to chromosome 13q12-13
In 1995, the BRCA2 gene was mapped to chromosomal 13q. Just fifteen months later, Wooster et al. reported…
-
Scientists cloned the tumor suppressor genes BRCA1 and BRCA2
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
